期刊文献+

重症肝病肝移植术后脑桥中央髓鞘溶解症的临床分析

Clinical analysis of 4 cases of central pontine myelinolysis occurring after liver transplantation
下载PDF
导出
摘要 目的探讨重症肝病肝移植术后早期出现脑桥中央髓鞘溶解症的发病原因及临床特征。方法对890例重症肝病肝移植患者临床资料进行分析,从而研究出中央髓鞘溶解症的发生率,并从临床分析中寻找中央髓鞘溶解症的可能原因。结果年龄在39。57岁的890例患者中有4例术后3~9d发生脑桥中央髓鞘溶解症,并且其中一例死亡。这4例的手术时间为(566±56)min。4例患者的肝和肾等功能障碍在手术前、后是处在不同程度并表现了相应的症状,如意识障碍,失语,颅神经受累,肢体运动障碍,精神和行为障碍。有3例纠正低钠血症血液中钠的波动范围在48h〉18mmol/L。结论肝功能,手术时问长,血浆渗透压急剧变化,是肝移植术后CPM的因素。 Objective To study the possible causes and clinical features of central pontine myelinolysis (CPM) occurring after liver transplantation . Methods 890 patients with severe liver diseases underwent liver transplantation. Their clinical data were analyzed to investigate the incidence of CPM and the clinical manifestations and possible causes of CPM. Results Four of the 890 patients, aged 39-57, suffered from CPM 3-9 days after the liver transplantation and 1 of them died. The operation time of the 4 cases was (566±56) minutes. All 4 cases showed liver and renal dysfunction at different degrees before the operation. Symptoms, such as disturbance of consciousness, aphasia, cranial nerve involvement, obstacle of limb movement, and mental and behavior disorders were seen. The fluctuation range of blood sodium in correction of hyponatremia during 48 h was 〉18 mmol/L in 3 cases. Conclusion Underlying liver function, long operation time, and abrupt change of plasma osmolality, is the factors of CPM after liver transplantation.
出处 《中国急救复苏与灾害医学杂志》 2012年第8期754-757,共4页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 肝移植 脑桥中央髓鞘溶解症 低钠血症 Liver transplantation Central pontine myelinolysis (CPM) hyponatremia
  • 相关文献

参考文献15

  • 1Lee YJ,Lee SG, Kwon TW, et al.Neuralogic complications after orthotopic liver transplantation including central pontin myelinolysis.Transplant Pro, 1996, 28:1674-1675.
  • 2Stemsia RH,Cappuccio JD,Silver SM,et al.Neurologic sequelae after treatment of severe hyponatremia :a multieenter perspeetive.J AM Soe Nephrol,1994,4:1522-1530.
  • 3Senzolo M,Ferronato C,Burra P.Neurologic complications after solid organ transplantion.Transplint, 2009,22(3):269-278.
  • 4Lien YH.Role of organic osmolytes in myelinolysis:a topographic study in rats after rapid correction of hyponatremia.J Clin Invest,1995,95:1579.
  • 5Yun BC,Kin WR,Benson JT,et al.Impaet of pretransplant hyponatremia on outcomefonowing livertransplantation.Hepatology,2009,49(5): 1610-1615.
  • 6蒋雯巍,蒋雨平.渗透性脱髓鞘综合征[J].中国临床神经科学,2007,15(3):306-309. 被引量:30
  • 7Lin SH, Hsu YJ, Chiu JS, et al. Osmotic demyclination syndrome:a potentially avoidable disaster.Q J Med, 2003,96:935-947.
  • 8Lin SH, Chau T, Wu CC. et al. Osmotic demyelination syndrome after correction of chronic hyponatremia with normal saline. Am J Med Sci,2002, 323:259-262.
  • 9刘树人,罗显荣,陈小平,骆丽敏,杨俊,朱新运,余宙耀.调整免疫抑制剂对肝移植感染预后的影响[J].中国危重病急救医学,2009,21(2):85-88. 被引量:11
  • 10Serkova NJ,Christians U,Benet LZ, Biochemical mechanisms of cyclosporine neurotoxicity.Mol Interv 2004;4:97-107.

二级参考文献53

  • 1王海灏,赵建平,张伟杰,曾凡军,陈知水,明长生,刘敦贵,林正斌,魏来,刘斌,蒋继贫,陈忠华.器官移植术后肺部感染的特点及治疗[J].中国抗感染化疗杂志,2005,5(6):355-357. 被引量:7
  • 2周俭,樊嘉,王征,吴志全,邱双健,黄晓武,孙健,肖永胜,汤钊猷,王玉琦.雷帕霉素转换治疗在肝癌肝移植中的初步经验[J].中华肝胆外科杂志,2006,12(4):280-281. 被引量:10
  • 3沈中阳,刘懿禾,王峪,刘蕾,明宇.成人肝移植围手术期多器官功能障碍综合征患者血清细胞因子的变化[J].中国危重病急救医学,2007,19(1):28-30. 被引量:10
  • 4蒋雯巍,孙小丰,蒋雨平.脑桥中央和脑桥外髓鞘溶解症的临床分析和影像特点[J].中国临床神经科学,2007,15(2):154-157. 被引量:20
  • 5Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsisrelated organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med, 1996,22 (7): 707-710.
  • 6Echaniz A, Pita S, Otero A, et al. Incidence, risk factors and influence on survival of infectious complications in liver transplantation. Enferm Microbiol Clin,2003,21 (5) :224-231.
  • 7[1]McAlister V,Gao Z,Peltekian K.Sirolimus-tacrolimus combination immanosuppression.Lancet,2000,355:376-377.
  • 8[2]Vasquez E.Sirolimus:a new agent for prevention of renal allograft rejection.Am J Health Syst Pharm,2000,57(5):437-448.
  • 9[3]Chang J,Mahanty H,Quan D.Experience with the use of sirolimus in liver transplantation-use in patients for whom calcineurin inhibitors are contraindicated.Liver Transpl,2000,6(6):734-740.
  • 10[4]Watson C,Friend P,Jamieson Y.Sirolimas:a potent new immunosuppressant for liver transplantation.Transplantation,1999,67(4):505-509.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部